Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Burning Rock Biotech Ltd ADR (NQ: BNR ) 6.320 +0.050 (+0.80%) Streaming Delayed Price Updated: 1:40 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Burning Rock Biotech Ltd ADR < Previous 1 2 Next > Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement June 03, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines May 30, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports First Quarter 2024 Financial Results May 29, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024 May 23, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024 May 14, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Publishes 2023 Annual Report on Form 20-F April 29, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces ADS Ratio Change April 26, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results March 28, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces Receipt of Notification from NASDAQ January 04, 2024 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces Results of 2023 Annual General Meeting December 19, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Third Quarter 2023 Financial Results November 30, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023 November 22, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023 November 20, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics October 30, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test October 15, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell September 07, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Second Quarter 2023 Financial Results August 31, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023 August 04, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces Resignation and Appointment of Directors June 28, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine June 08, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports First Quarter 2023 Financial Results May 30, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023 April 27, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Publishes 2022 Annual Report on Form 20-F April 20, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Fourth Quarter and Full Year 2022 Financial Results March 28, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023 March 07, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock provides an update on 2022 revenue guidance January 17, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test January 03, 2023 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Reports Third Quarter 2022 Financial Results November 15, 2022 From Burning Rock Biotech Limited Via GlobeNewswire Admission to Trading on the London Stock Exchange November 01, 2022 From Burning Rock Biotech Limited Via GlobeNewswire Burning Rock Announces Publication of Prospectus in connection with Direct Listing on the London Stock Exchange October 27, 2022 From Burning Rock Biotech Limited Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.